Test Price
2,800 AED✅ Home Collection Available
SLC35A1 Gene Sequencing Test for Congenital Disorder of Glycosylation Type 2F (NGS) in UAE | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Executive Summary:
This advanced genetic test utilizes Next‑Generation Sequencing (NGS) to precisely identify pathogenic variants in the SLC35A1 gene associated with Congenital Disorder of Glycosylation Type 2F, a rare inherited metabolic condition. Performed at our ISO‑accredited laboratory, the test achieves 99.9% diagnostic sensitivity. We provide premium logistics including hospital‑grade home collection via VIP Mobile Phlebotomy and ISO‑certified cold‑chain transport. Post‑test telephonic clinical guidance is included to support result interpretation. Direct billing verification is available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SLC35A1 NGS test sequences the entire coding region of the SLC35A1 gene using Illumina NovaSeq technology with >100× coverage, enabling detection of single‑nucleotide variants, small insertions/deletions, and splice‑site mutations. Orthogonal validation via LC‑MS/MS is performed for variants of clinical significance. This comprehensive approach ensures accurate diagnosis of Congenital Disorder of Glycosylation Type 2F, guiding appropriate clinical management and genetic counseling.
| Feature | Our Test (Premium) | Closest Alternative |
|---|---|---|
| Precision / Depth | Full‑gene NGS with >100× coverage | Targeted PCR‑based panels (limited to hotspots) |
| Methodology | Illumina NovaSeq – Gold Standard LC‑MS/MS orthogonal validation | Sanger sequencing or single‑exon analysis |
| Turnaround Time | 3–4 Weeks with ISO Cold‑Chain | 6–8 Weeks (standard lab) |
| Pre‑Test Genetic Counseling | Included (pedigree chart & DHA‑compliant session) | Often not provided |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize the profound impact a definitive molecular diagnosis can have on families navigating the complexities of inherited metabolic disorders. The SLC35A1 gene sequencing test offers a clear genetic answer, but it must always be interpreted alongside clinical findings and biochemical markers. I encourage patients to view this result as a cornerstone for a comprehensive, multidisciplinary care plan.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Medication Safety
Do not discontinue any prescribed medication or supplement without explicit instruction from your treating physician.
This test is a genetic screening tool; it does not replace clinical evaluation. In case of sudden neurological symptoms, severe vomiting, or unexplained seizures, seek emergency care immediately.
Exclusion Criteria & Pre‑Test Requirements
- Recent blood transfusion (within 4 weeks) may interfere with germline DNA analysis.
- Pre‑test genetic counseling session is mandatory – a pedigree chart of family members affected by glycosylation disorder type 2F must be completed prior to sample collection.
- Individuals under 18 require formal consent in compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability and the UAE Personal Data Protection Law.
Emergency Red Flags After Testing
- Acute metabolic decompensation (severe lethargy, hypoglycaemia, intractable vomiting).
- Unexplained neurological deterioration or stroke‑like episodes.
- Sudden cardiac arrhythmias in a known CDG context – call 998 immediately.
Patient FAQ & Clinical Guidance
1. What exactly does the SLC35A1 NGS test detect, and how long do results take?
This test reads the entire SLC35A1 gene to identify single‑nucleotide variants, small deletions, and duplications that cause Congenital Disorder of Glycosylation Type 2F, with reports delivered in 3 to 4 weeks after sample receipt at the laboratory.
2. Is home collection available, and how is my genetic data protected?
Yes, we offer VIP mobile phlebotomy with ISO‑certified cold‑chain transport across all UAE emirates. Your genetic data is secured under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning health information technology.
3. Do I need a doctor’s referral, and will the result include clinical guidance?
A physician’s referral is recommended but not mandatory; each report includes telephonic post‑test guidance from a DHA‑licensed medical geneticist to help you understand the findings and plan next steps.
UAE Regulatory & Data Privacy Adherence
This test is performed in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 concerning the Use of Information and Communication Technology in Health Fields. Personal and genetic data are processed under stringent confidentiality and security protocols. The laboratory holds ISO 9001:2015 certification and adheres to DHA standards for genetic testing and clinical governance.
Clinical & Logistical Metadata
| Test Name | SLC35A1 Gene Sequencing (NGS) – Congenital Disorder of Glycosylation Type 2F |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – VIP Mobile Phlebotomy & ISO Cold‑Chain Home Collection Available |
| Methodology Used | Next‑Generation Sequencing (Illumina NovaSeq) with LC‑MS/MS Orthogonal Validation |
| ICD-10-CM Code | E77.8 (Disorders of glycoprotein metabolism, other) |
| LOINC Code | 51904-2 (Genetic analysis of a specific gene) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians